26246878

Zaree M

2015

Expression Levels of PPAR? and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of ?-3 Fatty Acid.

26248242

Iwata MC

2015

Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.

26254797

Ohlsson Gotby A

2015

Congenital Adrenal Hyperplasia, Polycystic Ovary Syndrome and criminal behavior: A Swedish population based study.

26255520

Hao C

2015

[Acupuncture at Zhibian (BL 54) through Shuidao (ST 28) for polycystic ovary syndrome].

26255991

Joham AE

2016

Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.

26257142

Jin CH

2015

Body fat distribution and its associated factors in Korean women with polycystic ovary syndrome.

26258078

Salama AA

2015

Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome.

26261426

Palomba S

2015

Complications and challenges associated with polycystic ovary syndrome: current perspectives.

26264225

Figueroa F

2015

Role of macrophage secretions on rat polycystic ovary: its effect on apoptosis.

26265416

Ali AT

2015

Polycystic ovary syndrome and metabolic syndrome.

26267328

Razavi M

2016

Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome.

26269538

Daan NM

2015

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

26273622

Du T

2015

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome.

26273679

Chuang TY

2015

MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue.

26277181

Lis I

2015

[Omentin - a newly-discovered adipocytokine in insulin resistance pathogenesis].

26279073

Jamilian M

2015

Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

26279758

Li D

2015

Epigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome.

26280343

Mortada R

2015

Metabolic Syndrome: Polycystic Ovary Syndrome.

26282993

Wu S

2015

MicroRNA-132 promotes estradiol synthesis in ovarian granulosa cells via translational repression of Nurr1.

26283014

Shi L

2015

miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome.

26284813

Hayes MG

2015

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.

26284937

De Fr?ne V

2015

Quality of Life and Body Mass Index in Overweight Adult Women with Polycystic Ovary Syndrome During a Lifestyle Modification Program.

26288062

Micussi MT

2016

Relationship between pelvic floor muscle and hormone levels in polycystic ovary syndrome.

26288130

Traver S

2015

Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes.

26288196

Desai NA

2015

Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe?

26288450

Kura MM

2015

Acral Acanthosis Nigricans in a Case of Scleroderma.

26289303

Spritzer PM

2015

Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.

26291797

Maged AM

2015

The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome.

26291802

Aziz M

2015

Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.

26291804

Chun S

2015

1-h Postprandial glucose level is related to the serum anti-M?llerian hormone level in women with polycystic ovary syndrome.

26291814

G?ne? M

2015

Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.

26291816

Yang S

2016

Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?

26292090

Agacayak E

2015

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.

26294351

Amato MC

2015

Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.

26295295

Sahin FK

2015

Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.

26298265

Seo Y

2015

Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome.

26298524

Marzouk TM

2015

Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome.

26298813

Scalici E

2015

[Circulating nucleic acids and infertility].

26299777

Nugent D

2015

WITHDRAWN: Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.

26299778

Nahuis M

2015

WITHDRAWN: Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.

26304048

Huang X

2015

A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures.

26305227

Jones MR

2015

Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.

26306851

Walters KA

2016

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?

26308735

Shim U

2015

Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome.

26311969

Turan V

2015

Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study.

26312838

O'Reilly M

2015

Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome.

26314870

Sun X

2015

Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.

26315293

Ortega I

2015

Ovarian actions of resveratrol.

26315303

Jamilian M

2016

Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.

26320144

Victor VM

2015

Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance.

26321405

Pace JL

2015

Acne - a potential skin marker of internal disease.

26322372

Hurliman A

2015

Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).

26323652

Wu L

2015

Expression and contribution of the HIF-1?/VEGF signaling pathway to luteal development and function in pregnant rats.

26327459

Bui HN

2015

Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome.

26327878

Lenart-Lipi?ska M

2014

Polycystic ovary syndrome: clinical implication in perimenopause.

26327890

Stachowiak G

2015

Metabolic disorders in menopause.

26330853

Moti M

2015

Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome.

26335180

Ding Y

2016

The Mitochondrial tRNALeu(UUR) A3302G Mutation may be Associated With Insulin Resistance in Woman With Polycystic Ovary Syndrome.

26335185

Bagir GS

2016

Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.

26339397

Tao X

2015

Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide.

26339875

Calvar CE

2015

[High frequency of thyroid abnormalities in polycystic ovary syndrome].

26340353

Demir B

2015

The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome.

26340452

Karmarkar R

2015

Gynaecological pathology in women with Fowler's syndrome.

26340970

Vassilatou E

2015

Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease.

26341109

Enkhmaa B

2015

Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome.

26345811

Pan XY

2015

Effect of HIF-1a/VEGF signaling pathway on plasma progesterone and ovarian prostaglandin F?a secretion during luteal development of pseudopregnant rats.

26348137

Wang H

2015

Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function.

26350625

Weiss NS

2015

Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.

26351529

Tsikouras P

2015

Features of Polycystic Ovary Syndrome in adolescence.

26354094

Kuang H

2015

Predictors of participant retention in infertility treatment trials.

26354095

Kenigsberg LE

2015

Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.

26357661

Liu X

2015

Paracrine Regulation of Steroidogenesis in Theca Cells by Granulosa Cells Derived from Mouse Preantral Follicles.

26358939

Coles N

2016

Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome.

26359323

De Laveleye M

2015

Anti-M?llerian hormone testing: Evaluation of a novel method allowing more automation.

26360506

Homa LD

2015

Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).

26360602

Ramezani Tehrani F

2015

Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.

26361992

Unlu E

2016

Adrenal gland volume assessed by magnetic resonance imaging in women with polycystic ovary syndrome.

26364227

Tavakolian Arjmand A

2015

Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus.

26366087

Yang YM

2015

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome.

26368511

K???? A

2016

Clitoral and labial sizes in women w?th PCOS.

26369257

Taskin MI

2016

NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome.

26370242

Casarini L

2015

Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success.

26370491

Jia XZ

2015

Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis.

26370557

Sawada M

2015

Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.

26370923

Diri H

2016

Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.

26371381

Gourgari E

2015

Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

26372304

Churchill SJ

2015

Metabolic consequences of polycystic ovary syndrome.

26373789

Lin T

2015

Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study.

26373822

Dantas WS

2015

GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome.

26373866

Kartal D

2016

Association between isolated female acne and insulin resistance: a prospective study.

26376770

Anastasia K

2015

Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS).

26382159

Holloway V

2015

Sex drive and sexual desire.

26383179

Godoy-Gij?n E

2016

[New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases].

26384054

Dag ZO

2015

Autonomic dysfunction in patients with polycystic ovary syndrome.

26384059

Ko PC

2015

Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women.

26386293

Usadi RS

2015

Recruitment strategies in two reproductive medicine network infertility trials.

26386695

Pertynska-Marczewska M

2015

Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?

26387454

Huang R

2015

Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume.

26387747

Cheng F

2016

Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment.

26387977

Boyle JA

2015

Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.